Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
ClinicalTrials.gov study NCT06924398. IPD Sharing: NO. Countries: 1. Publications: 6.
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
ClinicalTrials.gov study NCT01859026. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
ClinicalTrials.gov study NCT02296203. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
ClinicalTrials.gov study NCT05338619. IPD Sharing: NO. Countries: 1. Publications: 2.
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
ClinicalTrials.gov study NCT07092202. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Uncommon EGFR AZD9291
ClinicalTrials.gov study NCT03424759. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical T
ClinicalTrials.gov study NCT06481566. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Meta
ClinicalTrials.gov study NCT05033691. IPD Sharing: UNDECIDED. Countries: 1. Publications: 15.
A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation
ClinicalTrials.gov study NCT03420079. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC
ClinicalTrials.gov study NCT04141644. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT04619563. IPD Sharing: NO. Countries: 1. Publications: 6.
A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT06015503. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases
ClinicalTrials.gov study NCT03497767. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure
ClinicalTrials.gov study NCT03802240. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
ClinicalTrials.gov study NCT03769103. IPD Sharing: NO. Countries: 1. Publications: 1.
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
ClinicalTrials.gov study NCT01994057. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)
ClinicalTrials.gov study NCT02293733. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC
ClinicalTrials.gov study NCT03046992. IPD Sharing: NO. Countries: 1. Publications: 5.
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06208033. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT01691391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.